Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The hypothesis is that povidone iodine alone is sufficient for sterilization of the lacrimal sac and eye lids before intraocular surgeries. Patients admitted for various intraocular surgeries will be randomly allocated to prophylactic local therapy with either moxifloxacin and povidone iodine or povidone iodine alone before surgery. Lacrimal sac and eye lid cultures will be obtained before the local therapy and just before surgery.
Over all 500 patients admitted for various intraocular surgeries will be included in the study. The study will be prospective, double blind, placebo controlled, and randomized. Patients will be randomly allocated to prophylactic local therapy with either moxifloxacin and povidone iodine or povidone iodine alone before surgery. For patients treated with povidone iodine alone a placebo will also be given. Lacrimal sac and eye lid cultures will be obtained before the local therapy and just before surgery. All patients will be followed for 6 weeks for symptoms and signs of infection. Bacterial and fungal culture results will be compared between the 2 groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Moxifloxacin and Povidone Iodine vs Povidone Iodine | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Type and amount of bacterial growth | ||
| Post surgery infections |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Orly Halachmi, MD | Contact | 972-4-649344 | ||
| Dan Miron, MD | Contact | 972-4-6404316 | miron_da@yahoo.om |
| Name | Affiliation | Role |
|---|---|---|
| Dan Miron, MD | HaEmek Medicak Center, Afula, Israel | Study Director |
| Orky Halachmi, MD | HaEmek Medical Center, Afula, Israel | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ophthalmology Department, HaEmek Medical Center, Afula, Israel | Recruiting | Afula | 18101 | Israel |
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 11, 2009 | |
| Reset | Jun 25, 2009 | |
| Release | Jul 22, 2009 | |
| Reset | Aug 27, 2009 | |
| Release | Sep 4, 2016 | |
| Reset | Oct 25, 2016 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 11, 2009 | Jun 25, 2009 | |||
| Jul 22, 2009 |
| ID | Term |
|---|---|
| D015817 | Eye Infections |
| ID | Term |
|---|---|
| D007239 | Infections |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077266 | Moxifloxacin |
| ID | Term |
|---|---|
| D024841 | Fluoroquinolones |
| D042462 | 4-Quinolones |
| D015363 | Quinolones |
| D011804 | Quinolines |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Aug 27, 2009 |
| Sep 4, 2016 | Oct 25, 2016 |
| D006574 |
| Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |